PROTAC CDK12/13 Degrader-1 (TFA)
PROTAC CDK12/13 Degrader-1 (7f) TFA is a highly selective cell cycle protein-dependent kinase CDK12/CDK13 dual degrader with the DC50 values of 2.2 nM and 2.1 nM, respectively. PROTAC CDK12/13 Degrader-1 TFA has anti-proliferative activity and can be used in breast cancer research[1].
Product Specifications
UNSPSC
12352005
Target
CDK; PROTACs
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; PROTAC
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/protac-cdk12-13-degrader-1-tfa.html
Purity
99.12
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(NCC1=CC=CC=C1)N([C@H]2CC[C@H](NC3=NC=C(C#N)C=C3)CC2)C4=CC=C(N5CCN(C(CNC6=CC7=C(C(N(C(CC8)C(NC8=O)=O)C7=O)=O)C=C6)=O)CC5)C=C4.O=C(O)C(F)(F)F
Molecular Formula
C47H47F3N10O8
Molecular Weight
936.93
References & Citations
[1]Jianzhang Yang, et al. Discovery of a Highly Potent and Selective Dual PROTAC Degrader of CDK12 and CDK13. J Med Chem. 2022 Aug 8.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK12; CDK13
Available Sizes
Explore Other Products
Browse additional items from our catalog
HOXD11, ID (HOXD11, HOX4F, Homeobox protein Hox-D11, Homeobox protein Hox-4F) (APC) discontinued
Recombinant Human Novel Coronavirus Spike glycoprotein (S) Protein
Recombinant Human Novel Coronavirus Spike glycoprotein (S) Protein
Recombinant Human Novel Coronavirus Spike glycoprotein (S) Protein
Recombinant Human Novel Coronavirus Spike glycoprotein (S) Protein